Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study
British Journal of General Practice · 2026
DOI: 10.3399/bjgp.2025.0780 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of General Practice, 2026. Verfasst von Cecilia Morel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Practice Patterns, Physicians', Primary Health Care, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prescribing patterns in primary care could demonstrate early clinical features of cancer and windows of opportunity for timely investigation.
Aim
To analyse primary care prescription patterns before a pancreatic cancer diagnosis. Design and setting Retrospective cohort study using linked primary care and cancer registry data from patients diagnosed with pancreatic cancer in England between 2011 and 2018.
Method
Prescription records registered in the Clinical Practice Research Datalink were analysed in the 5 years prediagnosis. Eight categories of prescriptions that may be used to treat clinical features of pancreatic cancer were included (anti-emetics, anti-reflux medications, insulin, other hypoglycaemic agents, opioids, non-opioid analgesics, neuropathic analgesics, and non-steroidal anti-inflammatories). Poisson regression was used to estimate the inflection points for increased prescribing above baseline.
Results
Among 12 990 patients, 669 287 prescriptions were analysed. Insulin was the least common prescription (6.9% [ n = 892/12 990] of patients), anti-reflux the most common (52.6% [ n = 6833/12 990] of patients). Insulin prescribing increased 19 months prediagnosis (95% confidence interval [CI] = 14.2 to 23.8), rising earlier in female patients (25 months; 95% CI = 17.4 to 32.5) than male patients (11 months; 95% CI = 5.8 to 16.2). Prescriptions for other hypoglycaemic agents increased 13 months (95% CI = 7.7 to 18.5), anti-reflux and opioid analgesic prescribing 7 months (95% CI = 5.4 to 8.6 and 4.4 to 9.6, respectively), and anti-emetics and non-opioid analgesics 5 months (95% CI = 2.9 to 7.1 and 3.2 to 6.8, respectively) before diagnosis.
Conclusion
The early increase in insulin prescribing suggests tumour-induced type 3c diabetes, highlighting an opportunity for earlier diagnosis in a small proportion of patients. Opportunities for earlier diagnosis through investigation and referral also exist in patients prescribed anti-emetic, anti-reflux, and analgesic medications in primary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
- Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
- Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK g.funston@qmul.ac.uk.
ORCID-Profile: Cecilia Morel, Kirsten D Arendse
Zitieren
APA
Morel, C., Walter, F. M., Virpal, P., Arendse, K. D., & Funston, G. (2026). Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study. British Journal of General Practice. https://doi.org/10.3399/bjgp.2025.0780
Vancouver
Morel C, Walter FM, Virpal P, Arendse KD, Funston G. Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study. British Journal of General Practice. 2026. doi:10.3399/bjgp.2025.0780
BibTeX
@article{Morel2026,
author = {Morel, Cecilia and Walter, Fiona M and Virpal, Pawandeep and Arendse, Kirsten D and Funston, Garth},
title = {Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study},
journal = {British Journal of General Practice},
year = {2026},
doi = {10.3399/bjgp.2025.0780}
}
EUVIMED